Clinton HIV/AIDS Initiative Partners With Pharmaceutical Companies to Reduce Cost of Antiretroviral Therapy
The partnerships with Pfizer, Mylan, and Mylan subsidiary Matrix Laboratories are designed to make better, more affordable treatments available for patients on second-line antiretroviral therapy in developing nations....